Sab Biotherapeutics, Inc.
Ticker: SABSW
| Insider | Title |
|---|---|
| Alexandra Kropotova | CHIEF MEDICAL OFFICER |
| Andrew Moin | Director |
| Bruce Kipp Erickson | Chief Operating Officer |
| Capital (master), L.p. Sessa | Director |
| Capital Gp, Llc Sessa | Director |
| Capital Im Gp, Llc Sessa | Director |
| Capital Im, L.p. Sessa | Director |
| Carlos N Carillo | SVP Regulatory Affairs |
| Charles Hiram Randall | Chief Strategy Officer |
| Christine E Hamilton | Director |
| Christoph Lawrence Bausch | CHIEF OPERATING OFFICER |
| David Charles Link | Director |
| Eddie Joe Sullivan | PRESIDENT, Director |
| Edward D. Hamilton | 10% or greater ownership |
| Erick Lucera | Director |
| Frederick Finnegan | Chief Business Officer |
| Helen K. Ellias | Director |
| Hua Wu | SVP Research Product Dev. |
| Ilan Katz | Director, 10% or greater ownership |
| Jay S Skyler | Director |
| Jeffrey G Spragens | Director |
| Jerry Lynn Pommer | Chief Compliance Officer |
| John Petry | Director |
| Lucy To | See Remarks |
| Mark William Conley | See Remarks |
| Melissa Vera Ullerich | Chief Communications Officer |
| Mervyn Turner | Director |
| Michael King | CHIEF FINANCIAL OFFICER |
| Russell P Beyer | Chief Financial Officer |
| Samuel J Reich | CEO EXECUTIVE CHAIRMAN, Director |
| Scott Giberson | Director |
| Thomas Charles Luke | Chief Medical Officer |
| William James Polvino | Director |